- Life Image launches Real World Imaging (RWI) offering to respond to researcher needs for maturing insights and accelerating drug development decisions.
- Imaging data, especially for Real World Evidence (RWE), has historically been difficult, if not impossible, to access, retrieve, view, de-identify and normalize at-scale, even though it provides clinically material insights for a growing number of therapies.
- Life Image represents the only company providing large,
Read More
Clinical Trial
UPenn Taps Medable’s Digital Trials Platform to Power LITE Psoriasis Study
The University of Pennsylvania School of Medicine has partnered with Medable, a provider of digital trials platform to accelerate patient enrollment and increase patient retention in the Light Treatment Effectiveness (LITE) study, which evaluates home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis.Phase 4 Pragmatic StudyMedable’s direct-to-patient app was selected for LITE, a Phase 4 pragmatic study that will enroll 1050 patients across 20-40 clinical
Read More
FDA Cancer OCE, Syapse Partner on Regulatory Use of Real-World Evidence (RWE)
Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement (RCA) focused on the use of real-world evidence (RWE) to support regulatory decision-making. Syapse and the OCE will work with stakeholders across the FDA to address key regulatory questions about testing and treatment patterns, dosing and safety, and outcomes in oncology, with a focus on precision medicine.Methods to Derive RWE From Multiple
Read More
Mercy Launches a Nationwide Real-World Evidence (RWE) Network to Pool De-Identified Patient Data
Mercy Technology Services (MTS), the information technology arm of St. Louis-based Mercy health system, has launched a nationwide real-world evidence network to pool clinical data for advanced analysis. The new initiative aims to create a new model of curated data sharing among providers, drug and device makers, regulators and more to power better patient care.MTS Real-World Evidence (RWE) Network BackgroundDeveloped in partnership with global tech giant SAP, MTS’ new network aims to tap into
Read More
What’s AI’s Holdup in Healthcare? The Answer Is In The Cloud
Fabien Beckers, Ph.D., CEO, Arterys
When you consider what technology has the most potential to transform healthcare over the next decade and beyond, no doubt your first thoughts turn to artificial intelligence (AI), machine learning (ML) and deep learning (DL). Already these technologies are showing promise in helping clinicians work faster and smarter, identifying trends, alerting us to signs that can predict and prevent diseases, and providing insights into potential treatments and
Read More
Human API Expands Their Consumer Driven Health Data Network to 85% Coverage of U.S. Hospitals
Health tech startup Human API today, announced it has vastly expanded their provider data network to drive the consumer health revolution forward. This first ubiquitous consumer health data network in the U.S. will allow people to securely share their data from anywhere with any company.Mission to Health Data Use & Sharing Simple & CentralizedIn their ambitious quest to make health data use and sharing simple and centralized, Human API now boasts a real-time, consumer-centric data
Read More
Yale, Mayo Clinic, Biofourmis Launches Research to Detect Heart Failure Using Wearable Biosensor Data
Biofourmis has entered a research partnership with the Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI). Biofourmis' mobile platform BiovitalsHFTM will be leveraged in a study of patients with heart failure to monitor functional capacity and quality of life to see if greater emphasis should be placed on these measures in the drug approval process.Impact of Heart FailureHeart failure afflicts approximately 6.5 million patients in the United States and
Read More
Notable Nabs $40M to Expand Drug Discovery Platform for Personalized Oncology
Notable, a San Francisco, CA-based company redefining cancer treatment with a clinically validated platform that rapidly advances cancer drug development has raised $40M in Series B funding. The Series B round is co-led by B Capital Group and LifeForce Capital. LifeForce is a returning investor, joined by new investors B Capital and Industry Ventures. This latest round brings Notable’s total funding to over $55M.Notable was founded in 2017 by Matt De Silva after helping his own father Marc, who
Read More
SubjectWell Raises $10M to Expand Risk-Free Clinical Trials Marketplace for Patient Recruitment
SubjectWell, an Austin, TX-based risk-free clinical trials marketplace for patient recruitment has raised $10 million in Series A funding led by Windham Venture Partners, with participation from previous investors Healthy Ventures and Geekdom Fund.
SubjectWell
Clinical Trials Marketplace
Founded in 2012, SubjectWell is increasing participation in clinical research by providing a single marketplace that allows prospective patients to match to any available clinical trials. Instead of using
Read More
Dassault Systèmes Acquires Clinical Trial Platform Medidata for $5.8B
French technology giant Dassault Systèmes has agreed to acquire Medidata, a life sciences digital transformation company in an all-cash deal for $92.25 per share valued at $5.8 billion. With the acquisition of Medidata and its clinical and commercial solutions, Dassault Systèmes plans to increase market penetration into the Life Sciences industry with an integrated business experience platform for an end-to-end approach to research and discovery, development, clinical testing, manufacturing and
Read More